Artificial Intelligence (AI) is at the heart of the latest global transformation, not least within the biopharmaceutical industry. AI is already rapidly redefining how we discover and design biologics ...

The FDA has published its first-ever guidance document on clinical trials with psychedelic drugs, an emerging treatment category for psychiatric and substance use disorders. The new document focuses ...